Last updated on September 2018

Does your child have ADHD?

Brief description of study

Evaluation of SPN-812ER 100 and 200mg Efficacy and Safety in Children with ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial

Detailed Study Description

To  evaluate  the  efficacy  of  SPN-812 extended  release  (ER)  compared  to  placebo  as monotherapy for the treatment of ADHD in children (6 -11 years)

Clinical Study Identifier: TX155570

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.